Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin

Overview

Journal Intern Med

Specialty General Medicine

Date 2017 Jul 5

PMID 28674347

Citations 20

Authors

Masutaka Furue

Gaku Tsuji

Takahito Chiba

Takafumi Kadono

Affiliations

Soon will be listed here.

Abstract

A close association of systemic inflammation with cardiovascular diseases and metabolic syndrome is recently a popular topic in medicine. Psoriasis is a chronic inflammatory skin disease with a prevalence of approximately 0.1-0.5% in Asians. It is characterized by widespread scaly erythematous macules that cause significant physical and psychological burdens for the affected individuals. The accelerated inflammation driven by the TNF-α/IL-23/IL-17A axis is now known to be the major mechanism in the development of psoriasis. Psoriasis is not a mere skin disease; it is significantly associated with cardiovascular diseases and metabolic syndrome, which suggests that the chronic skin inflammation extends the systemic inflammation beyond the skin. In this article, we review the epidemiological and pathological aspects of psoriasis and its comorbidities.

Citing Articles

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio associated with psoriasis: a cross-sectional study.

Liu X, Li K, Huang T, Tang H Front Med (Lausanne). 2024; 11:1514275.

PMID: 39712184 PMC: 11659000. DOI: 10.3389/fmed.2024.1514275.

Impact of a dermatological rehabilitation program on cardiovascular risks of psoriasis patients.

Attar J, von Martial S, Troost K, Neumeister T, Ehrchen J, Steinbrink K J Dtsch Dermatol Ges. 2024; 23(2):161-171.

PMID: 39538990 PMC: 11843430. DOI: 10.1111/ddg.15585.

Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis.

Wang C, Yuan J, Yu H, Lin J, Bai B Clin Cosmet Investig Dermatol. 2024; 17:2021-2037.

PMID: 39258216 PMC: 11386070. DOI: 10.2147/CCID.S470149.

A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting Atherosclerosis.

Letonja J, Petrovic D Biomedicines. 2024; 12(6).

PMID: 38927529 PMC: 11201627. DOI: 10.3390/biomedicines12061322.

Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis.

Kim N, Back J, Shin J, Ji M, Lee S, Park Y Sci Rep. 2023; 13(1):2869.

PMID: 36804462 PMC: 9938257. DOI: 10.1038/s41598-023-30103-2.

References

Kim D, Shin D, Lee M, Kim H, Kim D, Kim S . Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2015; 43(3):305-10. DOI: 10.1111/1346-8138.13061. View

Ansai S, Hashizume S, Kawana S, Tateishi C, Koga H, Hashimoto T . Case of anti-laminin gamma-1 pemphigoid with antibody against C-terminal domain of BP180 in a patient with psoriasis vulgaris. J Dermatol. 2014; 41(11):1031-3. DOI: 10.1111/1346-8138.12625. View

Ishida S, Takahashi K, Kanaoka M, Okawa T, Tateishi C, Yasukochi A . Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1. J Dermatol. 2015; 42(4):391-3. DOI: 10.1111/1346-8138.12801. View

Ohtsuki M, Morita A, Abe M, Takahashi H, Seko N, Karpov A . Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study. J Dermatol. 2014; 41(12):1039-46. DOI: 10.1111/1346-8138.12668. View

Okahashi K, Oiso N, Ishii N, Uchida S, Matsuda H, Hashimoto T . Bullous pemphigoid associated with psoriasis: A possible example of an inverse intramolecular epitope-spreading phenomenon. J Dermatol. 2015; 42(7):758-9. DOI: 10.1111/1346-8138.12891. View

Asahina A, Ohtsuki M, Etoh T, Gu Y, Okun M, Teixeira H . Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study. J Dermatol. 2015; 42(11):1042-52. DOI: 10.1111/1346-8138.13001. View

Herder C, Faerch K, Carstensen-Kirberg M, Lowe G, Haapakoski R, Witte D . Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. Eur J Endocrinol. 2016; 175(5):367-77. DOI: 10.1530/EJE-16-0528. View

Ha H, Wang H, Pisitkun P, Kim J, Tassi I, Tang W . IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci U S A. 2014; 111(33):E3422-31. PMC: 4143007. DOI: 10.1073/pnas.1400513111. View

Fumian M, Motta N, Maia R, Fraga C, Barreiro E, de Brito F . LASSBio-1425, an analog of thalidomide, decreases triglyceride and increases HDL cholesterol levels by inhibition of TNF-α production. Int J Cardiol. 2015; 202:497-9. DOI: 10.1016/j.ijcard.2015.09.071. View

10.

Nakamura K, Asano Y, Shibata S, Nakao M, Shida R, Takahashi T . Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment. J Dermatol. 2015; 42(10):1029-30. DOI: 10.1111/1346-8138.12996. View

11.

Grauballe M, Ostergaard J, Schou S, Flyvbjerg A, Holmstrup P . Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats. J Clin Periodontol. 2015; 42(9):807-816. DOI: 10.1111/jcpe.12442. View

12.

Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A . Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015; 42(4):367-72. DOI: 10.1111/1346-8138.12804. View

13.

Furue M, Kadono T . Psoriasis: Behind the scenes. J Dermatol. 2016; 43(1):4-8. DOI: 10.1111/1346-8138.13186. View

14.

Yamamoto T, Ohtsuki M, Sano S, Igarashi A, Morita A, Okuyama R . Epidemiological analysis of psoriatic arthritis patients in Japan. J Dermatol. 2016; 43(10):1193-1196. DOI: 10.1111/1346-8138.13342. View

15.

Piaserico S, Osto E, Famoso G, Zanetti I, Gregori D, Poretto A . Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis. Atherosclerosis. 2016; 251:25-30. DOI: 10.1016/j.atherosclerosis.2016.05.036. View

16.

Choi W, Park E, Kwon I, Kim K, Kim K . Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients. Ann Dermatol. 2010; 22(3):300-6. PMC: 2917683. DOI: 10.5021/ad.2010.22.3.300. View

17.

Naito R, Imafuku S . Distinguishing features of body mass index and psoriasis in men and women in Japan: A hospital-based case-control study. J Dermatol. 2016; 43(12):1406-1411. DOI: 10.1111/1346-8138.13439. View

18.

Kim D, Shin D, Jee H, Kim T, Kim S, Kim D . Red blood cell distribution width is increased in patients with psoriasis vulgaris: A retrospective study on 261 patients. J Dermatol. 2015; 42(6):567-71. DOI: 10.1111/1346-8138.12865. View

19.

Baurecht H, Hotze M, Brand S, Buning C, Cormican P, Corvin A . Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. Am J Hum Genet. 2015; 96(1):104-20. PMC: 4289690. DOI: 10.1016/j.ajhg.2014.12.004. View

20.

Lowes M, Suarez-Farinas M, Krueger J . Immunology of psoriasis. Annu Rev Immunol. 2014; 32:227-55. PMC: 4229247. DOI: 10.1146/annurev-immunol-032713-120225. View